Phoenix Biotech Acquisition Corp.

NASDAQ:PBAX

5.85 (USD) • At close February 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q3
Operating Activities:
Net Income -0.334-1.438-0.482-0.2630.085-0.112-0.378-0.315-0.001
Depreciation & Amortization 000000000
Deferred Income Tax 000000000
Stock Based Compensation 000000000
Change In Working Capital 0.1990.7050.3921.4530.7230.140.097-0.3660.001
Accounts Receivables 000000000
Change In Inventory 000000000
Change In Accounts Payables 0.1651.1290.3640.9430.5470.0420.1070.0130.001
Other Working Capital 0.034-0.424-0.3640.510.1750.098-0.01-0.380
Other Non Cash Items -0.122-0.151-0.109-1.563-0.982-0.265-0.027-0.0160
Operating Cash Flow -0.256-0.883-0.198-0.373-0.174-0.237-0.308-0.6970
Investing Activities:
Investments In Property Plant And Equipment 000000000
Acquisitions Net 000000000
Purchases Of Investments -0.069-0.275-0.1-0.32500000
Sales Maturities Of Investments 5.0790.560000000
Other Investing Activites 0.67900181.03600000
Investing Cash Flow 5.6890.285-0.1180.711000-178.50
Financing Activities:
Debt Repayment 000000000
Common Stock Issued 000000000
Common Stock Repurchased -5.63900-139.35400000
Dividends Paid 000000000
Other Financing Activities -5.4190.5250-138.70400000
Financing Cash Flow -5.4190.5250-000000
Other Information:
Effect Of Forex Changes On Cash -0.01600-138.70400000
Net Change In Cash 0.014-0.073-0.29841.634-0.046-0.237-0.308-179.1970
Cash At End Of Period 0.1190.1050.17842.1420.5080.5540.791.0990